TD Waterhouse Canada’s GSK GSK Stock Holding History

TD Waterhouse Canada’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.12M	Buy	41,253 +8,296	+25%	+$439K	0.01%	582
2026 Q1	$1.85M	Buy	32,957 +12,229	+59%	+$663K	0.01%	571
2025 Q4	$1.02M	Buy	20,728 +245	+1%	+$11.4K	0.01%	561
2025 Q3	$932K	Sell	20,483 -195	-0.9%	-$7.62K	0.01%	569
2025 Q2	$805K	Sell	20,678 -127	-0.6%	-$4.85K	0.01%	572
2025 Q1	$788K	Sell	20,805 -158	-0.8%	-$5.78K	0.01%	565
2024 Q4	$709K	Buy	20,963 +1,332	+7%	+$48K	0.01%	562
2024 Q3	$791K	Buy	19,631 +1,779	+10%	+$72.8K	0.01%	538
2024 Q2	$686K	Buy	17,852 +81	+0.5%	+$3.41K	0.01%	547
2024 Q1	$776K	Sell	17,771 -616	-3%	-$25.4K	0.01%	546
2023 Q4	$750K	Buy	18,387 +374	+2%	+$13.4K	0.01%	465
2023 Q3	$680K	Sell	18,013 -805	-4%	-$28.6K	0.01%	476
2023 Q2	$681K	Buy	18,818 +1,522	+9%	+$54.6K	0.01%	478
2023 Q1	$638K	Buy	17,296 +242	+1%	+$8.47K	0.01%	489
2022 Q4	$617K	Sell	17,054 -1,542	-8%	-$51.4K	0.01%	488
2022 Q3	$571K	Buy	18,596 +785	+4%	+$29.8K	0.01%	483
2022 Q2	$1M	Sell	17,811 -3,030	-15%	-$167K	0.01%	411
2022 Q1	$1.15M	Sell	20,841 -44,133	-68%	-$2.4M	0.01%	423
2021 Q4	$3.57M	Buy	+64,974	New	+$3.38M	0.03%	267

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

TD Waterhouse Canada's GSK Position: Q2 2026 in Review

TD Waterhouse Canada increased its GSK (GSK) stake by 25% in Q2 2026, buying an estimated $439K and bringing the position to 41,253 shares worth $2.12M. The position accounts for 0.01% of the portfolio, ranked #582.

TD Waterhouse Canada first reported a position in GSK in Q4 2021 and has held it in 19 quarters since. The position peaked at $3.57M in Q4 2021. 1,045 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

TD Waterhouse Canada held 41,253 shares of GSK worth $2.12M as of Q2 2026.
TD Waterhouse Canada bought 8,296 GSK shares in Q2 2026, an estimated $439K.
GSK made up 0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #582 holding.
TD Waterhouse Canada first reported a position in GSK in Q4 2021 and has held it in 19 quarters since.
TD Waterhouse Canada's GSK position peaked at $3.57M in Q4 2021.
1,045 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.